Who can take the vaccine?

Vaccination is recommended for persons with comorbidities that have been identified as
increasing the risk of severe COVID-19, including obesity, cardiovascular disease and respiratory disease.
The vaccine can be offered to people who have had COVID-19 in the past.

Who is the vaccine not recommended for?

Individuals with a history of anaphylaxis to any component of the vaccine should not take it.
Persons with acute PCR-confirmed COVID-19 should not be vaccinated until after they have recovered
from acute illness and the criteria for ending isolation have been met.
Anyone with a body temperature over 38.5Â°C should postpone vaccination until they no longer have a fever.

How efficacious is the vaccine?

A large phase 3 trial in Brazil showed that two doses, administered at an interval of 14 days,
had an efficacy of 51% against symptomatic SARS-CoV-2 infection,
100% against severe COVID-19, and 100% against hospitalization starting 14 days after receiving the second dose.